LENZ Therapeutics was thrilled with the excitement at our capacity capped Key Opinion Leader (KOL) medical meeting in Nashville last night. Thank you to the panel of investigators, Marc Bloomenstein,O.D., Milton Hom, O.D., Natasha Hindman, O.D., from our Phase 3 CLARITY trial who shared their perspectives on Aceclidine, S. Barry Eiden for moderating the panel and the 100+ ECPs who joined us at the event overlooking Nashville downtown. Make sure to stop by Booth #1103 at the American Optometric Association convention today to learn more about the future of presbyopia solutions. #Presbyopia
LENZ Therapeutics’ Post
More Relevant Posts
-
From May 30 to 31, don’t miss the panel of international experts and attend sessions on AF ablation, ventricular arrythmias and several cases sessions. 👉 Take a look at the synoptic: https://lnkd.in/gks5sBnA The course directors : Jean paul Albenque, Clement Bars, MD, Sonia Busch, K.R. Julian Chun, Deisenhofer Isabel, Tom De Potter, Franck Halimi, Julien Seitz, MD The partners of the Rhythm 2024 congress : Medtronic, Abbott, MicroPort, Biosense Webster, Volta, Boston Scientific, GE HealthCare, Bristol Myers Squibb #Rhythm2024 #RhythmCongress #Arrhythmias #HeartFailure #Rhythmology
To view or add a comment, sign in
-
-
Join us at the Cardiovascular Tech Summit panel discussion where we dive into the crucial topic of "First-in-Human Trials: Paving the Pathway for Promising Innovations." We'll explore the best approaches to transition from preclinical studies to initial human testing, and delve into the intricacies of applying for first-in-human studies in the United States. Our esteemed panelists include: - Jeff Daurity - Senior Director, Clinical Strategy and Operationalization, Medical Devices & Diagnostics at ICON (Moderator) - Adam Berman, CEO, Alleviant Medical, Inc. - William Cohn, MD - Executive Director for the Center of Device Innovation at the Texas Medical Center, CMO of BiVACOR Inc., CMO of Obvius Robotics. - Saibal Kar, MD - Director of Structural Heart Disease and Research at HCA Healthcare - Arshad Quadri, MD - inQB8 Medical Technologies We'll also explore the significance of patient preferences in Clinical Studies within the realm of Cardiovascular Medicine, and how the patient's voice is taken into consideration. Register Here: https://bit.ly/3s9dL6s #CTS2023 #HealthcareInnovation #ClinicalStudies #CardiovascularMedicine #MedicalInnovation
To view or add a comment, sign in
-
-
In this episode, host Dr. Bryan Hartley takes us on a deep dive into the origin story and mission of Pulmera, a medtech company dedicated to transforming the field of bronchoscopic lung cancer diagnosis by retrofitting existing fluoroscopy machines into cone beam CT-like scanners. Dr. Hartley is an interventional radiologist and co-founder Pulmera. Pulmera is developing a novel approach to enhance physicians’ ability to diagnose lung nodules accurately through innovative technology. Dr. Hartley shares insights into the challenges of existing diagnostic methods, the inspiration behind Pulmera, and the technology’s potential to combine the best of 3D imaging and endoscopy techniques. Dr. Hartley discusses the benefits for both patients and physicians, such as improved diagnostic yields and patient outcomes, and introduces an investment opportunity for the BackTable community to be part of this revolutionary project. The episode also explores the broader implications of this technology across various medical specialties beyond pulmonology. Stream here: https://lnkd.in/e7bMQteX #InterventionalRadiology #InterventionalPulmonology #Pulmonology #PhysicianEntrepreneur #StartUp #LungNodule #MedicalImaging #INN74
Pulmera’s Journey From Concept to Clinical Impact w/ Dr. Bryan Hartley | BackTable Ep. 74
https://www.youtube.com/
To view or add a comment, sign in
-
Chief Commercial Officer - Spesana | Innovative Servant Leader | Healthcare Ecosystem Enhancements | Precision Medicine | Decision Support Solutions | Companion Diagnostics | Health Equity | Revenue Cycle Optimization
The transformation of healthcare and the drive to enhance patient care can only be achieved through strong partnerships. The shared mission of Velatura Public Benefit Corporation & Spesana is changing the continuum of care for clinicians and patients. Improved prior authorization means faster time to diagnosis and faster time to treatment. #partnerships #precisionmedicine #priorauthorization #healthcare #transformation #hie #interoperability #patientcare #moleculardiagnostics
Last month, Velatura and Spesana announced a pilot project that promises to propel the advancement of precision medicine and transform the prior authorization process for oncologists and specialty providers. Learn more about the impact here. ⬇
To view or add a comment, sign in
-
Make sure not to miss out on this excellent webinar!
Join us on 29 January at 16:00 CET, for a patient-outcome-focused broadcast showcasing the Next Gen Closurefast™️ application for varicose vein treatment. 🔗 https://ow.ly/SFf850QjQ85 This broadcast aims to: - Provide insight into Next Gen Closurefast’s key features - Explore its real-world applications - Provide a Q&A with the engineers responsible for its creation and implementation Supported by Medtronic Cardiac and Vascular Vanessa L., Domenico Baccellieri, Juan Manuel Fontcuberta García., Chuanjing Xu, John Elhard, Sarah Thole
To view or add a comment, sign in
-
-
With Zenition 30, you can unlock high-quality imaging for a wide variety of procedures and patients, including pediatric patients, featuring enhanced efficiency, unify workflow to reduce miscommunication during imaging. Learn more about it's advantages by joining us at UKIO! https://lnkd.in/eW4FWYRV #UKIO #IGT #Philips
To view or add a comment, sign in
-
-
Video 1 | When we say virtually invisible, we mean it. We are excited to start sharing some learnings from our Lumbar Injectrode Feasibility Evaluation (LIFE) first-in-human clinical trial. This video shows the Injectrode placement site immediately after placement on day 0, and then again on day 25. As you’ll see, the Injectrode is virtually invisible from the outside! Stay tuned for more highlights from the LIFE study and a full press release next week. #Injectrode #PainManagement #MedicalDevice #Neuromodulation
To view or add a comment, sign in
-
🎞 Watch the Amazing Highlights of the most recent Precision in Clinical Trials #PCTSUMMIT & Precision in Medical Devices #PMDSUMMIT that recently happened at the Hilton Boston Park Plaza on May 6th-7th, 2024. Link to Watch ➡ : https://lnkd.in/eRYsJi3u This #Summit brought together numerous #Biopharma leaders that discussed the recent wave of #Innovation that is coming to the #ClinicalTrials and #DrugDevelopment industry in 2024 and beyond. Email us at info@Precision-Globe.com to learn about our upcoming #LifeSciences Events, you can also learn more by visiting the link below: 📲 https://lnkd.in/ecp62Jy #DigitalHealth #EastCoast #LifeSciences #ClinicalDevelopment #CRO #ClinicalOperations #AI #ML #Datamanagement #Biostats #MedTech #MedicalDevices #Pharma #Biotech #Diagnostics #Therapeutics #Medicine #Patients #Oncology #RareDisease #CNS #Neurology #TherapeuticFocused #PatientRecruitment #Marketing
Highlights of the Precision in Clinical Trials Summit at the Hilton Boston Park Plaza May 2024
https://www.youtube.com/
To view or add a comment, sign in
-
#SCOPE2024 is almost here! Interested in simplifying and scaling your clinical research program with one imaging workflow platform across all sites, stakeholders, and trials? Be sure to connect with our team at the event and find out how! Schedule a meeting here --> https://zurl.co/fV8X #SCOPEsummit #clinicalresearch #clinicaltrials #clinicalworkflow
To view or add a comment, sign in